908 Devices Inc. (MASS)
908 Devices Inc. operates in the Medical - Specialties industry of the Healthcare sector, headquartered in Burlington, MA, US. The stock last traded at $9.87, down 1.44% on the session, giving a market capitalisation of $404.8M. On trailing twelve-month figures it carries a trailing P/E of -10.61, a net margin of -56.7%. Its beta of 0.63 implies it has historically moved less than the broad market.
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
908 Devices Inc. is most often compared with the following Healthcare names: